23andMe Holding Co (ME)
0.4235
+0.01
(+1.39%)
USD |
NASDAQ |
Jun 21, 16:00
0.4226
0.00 (0.00%)
After-Hours: 20:00
23andMe Cash from Operations (Quarterly): -25.78M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -25.78M |
| December 31, 2023 | -12.06M |
| September 30, 2023 | -57.12M |
| June 30, 2023 | -69.36M |
| March 31, 2023 | -44.96M |
| December 31, 2022 | 25.54M |
| September 30, 2022 | -72.93M |
| June 30, 2022 | -73.04M |
| Date | Value |
|---|---|
| March 31, 2022 | -35.20M |
| December 31, 2021 | -24.60M |
| September 30, 2021 | -62.49M |
| June 30, 2021 | -44.53M |
| March 31, 2021 | -40.27M |
| December 31, 2020 | 28.43M |
| September 30, 2020 | -29.51M |
| June 30, 2020 | -32.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-73.04M
Minimum
Jun 2022
28.43M
Maximum
Dec 2020
-35.67M
Average
-37.74M
Median
Cash from Operations (Quarterly) Benchmarks
| RadNet Inc | 17.08M |
| DermTech Inc | -17.12M |
| iSpecimen Inc | -2.072M |
| Sera Prognostics Inc | 4.994M |
| Progyny Inc | 25.73M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.146M |
| Cash from Financing (Quarterly) | 2.00M |
| Free Cash Flow | -173.98M |
| Free Cash Flow Per Share (Quarterly) | -0.0575 |
| Free Cash Flow to Equity (Quarterly) | -27.95M |
| Free Cash Flow to Firm (Quarterly) | -27.95M |
| Free Cash Flow Yield | -86.31% |